MedImmune FluMist Facility Receives FDA Approval
This article was originally published in The Pink Sheet Daily
The company also plans to use the new plant located in Speke, England to manufacture its FluMist follow-on CAIV-T.
You may also be interested in...
FDA seeks clarification on data already submitted to support approval of the influenza vaccine sBLA.
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13